Table 1 Demographic and clinical characteristics and ophthalmologic measurements of patients with transfusion-dependent β-thalassemia
From: Ocular findings in patients with transfusion-dependent β-thalassemia in southern Iran
Variables | Values |
|---|---|
Age (year) | 28.4 ± 5.6 (18–43) |
Ferritin (ng/ml) | 2245 ± 1623 (300–7500) |
Weight (kg) | 52 ± 7.7 (36–85) |
Hemoglobin (g/dl) | 9.8 ± 0.67 (8.1–11.1) |
Splenectomy (yes) | 29 (36.7) |
Sex (male) | 24 (30.4) |
Comorbiditiesa | 36 (45.5) |
Diabetes mellitus | 28 (35.4) |
Heart disease | 2 (2.6) |
Hypothyroidism | 2 (2.6) |
Hypoparathyroidism | 1 (1.3) |
Osteoporosis | 3 (3.8) |
Amenorrhea | 1 (1.3) |
Type of iron-chelating therapy in the last 2 years | |
Deferoxamine | 13 (16.5) |
Deferasirox | 27 (34.2) |
Deferoxamine and Deferasirox | 12 (15.2) |
Deferoxamine and Deferiprone | 27 (34.2) |
VA (decimal) | 0.960 ± 0.086 |
VA (logMar) | 0.016 ± 0.046 |
0 | 69 (87.3) |
0.1 | 7 (8.9) |
> 0.1 | 3 (3.8) |
Intraocular pressure (mmHg) | 14.88 ± 3.34 |